119 related articles for article (PubMed ID: 34374293)
1. Alternations of N-glycans recognized by Phaseolus vulgaris leucoagglutinin in the saliva of patients with breast cancer.
Yang J; Ma T; Yu H; Yin M; Qiao Y; Niu L; Yang F; He J; Li Z
Neoplasma; 2021 Sep; 68(5):994-1004. PubMed ID: 34374293
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Galactosylated-Glycans recognized by Bandeiraea Simplicifolia Lectin I in saliva of patients with breast Cancer.
Yang J; Liu X; Shu J; Hou Y; Chen M; Yu H; Ma T; Du H; Zhang J; Qiao Y; He J; Niu L; Yang F; Li Z
Glycoconj J; 2020 Jun; 37(3):373-394. PubMed ID: 32103424
[TBL] [Abstract][Full Text] [Related]
3. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
4. Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer.
Shu J; Yu H; Du H; Zhang J; Zhang K; Li X; Xie H; Li Z
Cancer Biomark; 2018; 22(4):669-681. PubMed ID: 29865036
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
6. Integrated glycomics strategy for galactosylated-N-glycans recognized by Bandeiraea Simplicifolia Lectin I in salivary proteins associated with lung cancer.
Zhang F; Xie M; Tang Z; Xie H; Yue L; Wang X; Yang J; Chen Y; Li Z
Proteomics Clin Appl; 2023 May; 17(3):e2200012. PubMed ID: 36349801
[TBL] [Abstract][Full Text] [Related]
7. Alterations of mannosylated glycopatterns recognized by Hippeastrum hybrid lectin in saliva of patients with lung cancer.
Zhang F; Xie M; Tang Z; Wang Y; Du J; Yu H; Du H; Shu J; Chen Y; Yang F; Li Z
Clin Oral Investig; 2024 Jun; 28(7):360. PubMed ID: 38847917
[TBL] [Abstract][Full Text] [Related]
8. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis for Glycopatterns and Complex-Type
Qin X; Guo Y; Du H; Zhong Y; Zhang J; Li X; Yu H; Zhang Z; Jia Z; Li Z
Front Physiol; 2017; 8():596. PubMed ID: 28871230
[No Abstract] [Full Text] [Related]
10. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
[TBL] [Abstract][Full Text] [Related]
11. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
12. Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer.
Blaschke CRK; Hill EG; Mehta AS; Angel PM; Laronga C; Drake RR
Sci Rep; 2022 Dec; 12(1):20801. PubMed ID: 36460712
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
[TBL] [Abstract][Full Text] [Related]
14. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
17. N-glycan profiles in H9N2 avian influenza viruses from chicken eggs and human embryonic lung fibroblast cells.
Chen W; Zhong Y; Su R; Qi H; Deng W; Sun Y; Ma T; Wang X; Yu H; Wang X; Li Z
J Virol Methods; 2017 Nov; 249():10-20. PubMed ID: 28797655
[TBL] [Abstract][Full Text] [Related]
18. Identification of aberrantly expressed glycans in gastric cancer by integrated lectin microarray and mass spectrometric analyses.
Li X; Guan F; Li D; Tan Z; Yang G; Wu Y; Huang Z
Oncotarget; 2016 Dec; 7(52):87284-87300. PubMed ID: 27895315
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
20. The Abnormal Glycopatterns of Salivary Glycoproteins in Esophageal Squamous Cell Carcinoma Patients.
Shu J; Ma J; Ren X; Wang J; Wang Y; Zhang K; Yu H; Guo X; Li Z
Front Chem; 2021; 9():637730. PubMed ID: 33748076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
